Taproot Medical Technologies
IT services and business technology solutions
- Sector
- Medtech
- Headquarters
- Seattle, WA
- Founded
- 2016
- Latest Form D
- $1.2M, Mar 2018
- Total capital
- $2.2M
- Federal grants
- $958K
- 2 awards · 2018–2019
- Rank in peer group#22 of 27
- Private capital raised
- $1.2M
- 1 Form D · last Mar 2018
- 104 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 5 pending · first 2025
- Rank in peer group#7 of 27
Capital timeline
Latest events
- Federal grantNSF · Phase II · SBIR Phase II: Development of Injectable, Enzyme-Degradable Poly(carboxybetaine) Hydrogel Formulations as Aesthetic and Surgical Tissue Fillers$733K
- Private capital raisedForm D · SEC · 1st filing$1.2M
- Federal grantNSF · Phase I · SBIR Phase I: Development of Injectable, Enzyme-Degradable Poly(carboxybetaine) Hydrogel Formulations as Aesthetic and Surgical Tissue Fillers$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
2months
from Taproot Medical Technologies’s first federal award to its first private round.
- First federal award · Jan 2018
- NSF · $225K
- First Form D · Mar 2018
- $1.2M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 27 peers
Line = medianMedtech · Material
- Federal grantsBelow median
- Granted patents#7 · top 26%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Jens QuistgaardExecutive Officer, DirectorNamed in SEC Form D filings
- Shaoyi JiangExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 6- PendingHydrogel Compositions Based On Polysaccharides And Zwitterionic Polymers, And Methods For Their UseUSPTOApplication 19338462
- GrantedHydrogel Compositions Based On Polysaccharides And Zwitterionic Polymers, And Methods For Their UseUSPTOUS 12,448,498
- PendingPolyzwitterionic Stabilized Protein FormulationsUSPTOApplication PCTUS2025044704
Show all 6 patent records
- Hydrogel Compositions Based On Polysaccharides And Zwitterionic Polymers, And Methods For Their UseJan 15, 2026 · Application 19338462Pending
- Hydrogel Compositions Based On Polysaccharides And Zwitterionic Polymers, And Methods For Their UseOct 21, 2025 · US 12,448,498Granted
- Polyzwitterionic Stabilized Protein FormulationsApplication PCTUS2025044704Pending
- Polyzwitterionic Stabilized Protein FormulationsApplication 63690491Pending
- Hydrogel Compositions Based On Polysaccharides And Zwitterionic Polymers, And Methods For Their UseApplication PCTUS2019065630Pending
- Hydrogel Compositions Based On Polysaccharides And Zwitterionic Polymers, And Methods For Their UseApplication 62782213Pending
Related companies, and why
- SENSVITA INC.Similar federal contract value in Medtech · null in contracts
- ParaNano Wound Care, LLCSimilar federal contract value in Medtech · null in contracts
- FireHUD, Inc.Similar federal contract value in Medtech · null in contracts
- Jade TherapeuticsSimilar federal contract value in Medtech · null in contracts
- OSTEOVANTAGE, INCSimilar federal contract value in Medtech · null in contracts
- WISEWEAR CORPORATIONSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .